[1]

LI Li, SHI Huaying, Zaxiyangzong , Dawazhuoma , CHEN Yanmei, YANG Chunjiao, WEN Honglin. Application of indirect method in establishing reference range of adult blood lipids in Lhasa [J]. Laboratory Medicine, 2025, 40(11): 1064-1069.

[2]

[3]

CHEN Wenli, JIN Cheng, ZHOU Lulu, XU Weiyi. Role of MicroR in guiding platelet count re-examination [J]. Laboratory Medicine, 2025, 40(9): 897-900.

[4]

WANG Qiuju, XIAO Huijian, WU Shuang, ZHAO Wanting, DAI Xubo, ZHUANG Yuepeng. Role of peripheral blood lymphocyte morphological classification in curative effect judgment of critical influenza [J]. Laboratory Medicine, 2025, 40(9): 901-906.

[5]

[6]

SHI Shaoxin, CHEN Xueting, XU Xiaofeng, LU Renquan, GUO Lin, ZHUANG Yihui. Role of coagulation function in bacterial bloodstream infection among malignant tumor patients [J]. Laboratory Medicine, 2025, 40(8): 804-809.

[7]

JIANG Fengying, JIANG Yun, MI Rui, QIAN Ximing, WANG Qiubo. Changes of platelet and coagulation function indicators in elderly patients with diabetic foot ulcers [J]. Laboratory Medicine, 2025, 40(7): 708-712.

[8]

[9]

DAI Jingwen, YANG Shuo, WANG Chong, SUN Lin, GU Meixiu, XIAN Jingrong, PAN Baishen, WANG Beili, ZHANG Chunyan, GUO Wei. Role of preoperative mean corpuscular hemoglobin concentration for predicting postoperative recurrence in intrahepatic cholangiocarcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 344-349.

[10]

ZHANG Haoyang, LU Lin, ZONG Ming, HE Long, DING Yuanyuan, FAN Lieying. Diagnostic and predictive value of white blood cell population data in patients with sepsis [J]. Laboratory Medicine, 2025, 40(3): 271-277.

[11]

ZHOU Jiakuan, GUO Ping, CAI Qi, YANG Mingkang, HUANG Zhixi, XUE Yilun, HUA Renxiang, LIN Han, LI Jiaming, WANG Jianbiao. Molecular epidemiological analysis of patients with increased stomatocytes and giant platelets in peripheral blood [J]. Laboratory Medicine, 2025, 40(2): 171-177.

[12]

WANG Chengyun, GU Ping, PAN Qiuhui, WANG Jing. Changes and clinical value of blood coagulation indexes in children with infection [J]. Laboratory Medicine, 2025, 40(2): 178-181.

[13]

. [J]. Laboratory Medicine, 2025, 40(2): 197-200.

[14]

ZHANG Lan, ZHU Jianfeng, PAN Baishen, CHEN Pu, WANG Beili, GUO Wei. Prognostic value of circulating plasma cells determined by morphology in newly diagnosed multiple myeloma [J]. Laboratory Medicine, 2025, 40(1): 15-19.

[15]

CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026.

异淋百分比（%）	白细胞计数(×10⁹/L)	淋巴百分比（%）	单核百分比（%）	淋巴细胞绝对值(×10⁹/L)
5	16.8	64.4	7.8	10.8
5	30.1	56.5	7.3	17.0
5	28.4	54.8	12.7	15.6
5	16.1	62.6	4.4	10.1
6	15.8	64.5	7.2	10.2
6	17.2	64.1	14.3	11.0
6	18.0	63.1	8.7	11.4
6	11.6	62.3	17.0	7.2
6	16.4	74.9	4.8	12.3
7	22.8	61.7	14.1	14.1
7	10.0	80.1	3.0	8.0
7	10.1	59.5	13.6	6.0
8	15.7	78.3	4.2	12.3
8	19.9	69.8	11.0	13.9
8	24.6	73.8	8.7	18.2
8	12.3	65.6	11.9	8.1
9	14.5	55.8	12.1	8.1
10	13.0	57.1	9.1	7.4
10	11.9	59.0	11.4	7.0
10	16.3	71.9	8.3	11.7
11	15.7	69.4	9.3	10.9
11	19.2	65.7	5.3	12.6
12	16.2	65.0	10.0	10.5
13	19.3	73.5	12.3	14.2
13	5.5	66.7	9.0	3.7
14	8.7	71.0	5.5	6.2
15	24.5	49.6	15.6	12.2
15	20.7	76.2	5.2	15.8
15	20.6	64.2	6.4	13.2
16	22.6	71.1	10.0	16.1
17	9.1	67.6	6.6	6.2
17	24.3	49.8	15.3	12.1
17	9.1	67.6	6.6	6.2
18	23.0	66.3	13.1	15.2
18	7.6	73.8	5.1	5.6
18	23.2	63.2	13.8	14.7
18	13.0	55.0	10.9	7.2
18	15.7	67.4	14.7	10.6
20	9.1	62.6	7.8	5.7
21	18.7	57.8	12.8	10.8
21	9.3	46.8	13.3	4.4
23	17.0	53.0	15.7	9.0
25	13.5	54.7	12.4	7.4
28	21.1	54.0	18.1	11.4
28	22.9	70.0	10.9	16.0
28	22.8	67.0	11.6	15.3
28	20.3	67.4	12.6	13.7
34	18.0	71.0	12.1	12.8
48	16.5	77.2	4.7	12.7

异淋百分比（%）	白细胞计数(×10⁹/L)	淋巴百分比（%）	单核百分比（%）	淋巴细胞绝对值(×10⁹/L)
5	16.8	64.4	7.8	10.8
5	30.1	56.5	7.3	17.0
5	28.4	54.8	12.7	15.6
5	16.1	62.6	4.4	10.1
6	15.8	64.5	7.2	10.2
6	17.2	64.1	14.3	11.0
6	18.0	63.1	8.7	11.4
6	11.6	62.3	17.0	7.2
6	16.4	74.9	4.8	12.3
7	22.8	61.7	14.1	14.1
7	10.0	80.1	3.0	8.0
7	10.1	59.5	13.6	6.0
8	15.7	78.3	4.2	12.3
8	19.9	69.8	11.0	13.9
8	24.6	73.8	8.7	18.2
8	12.3	65.6	11.9	8.1
9	14.5	55.8	12.1	8.1
10	13.0	57.1	9.1	7.4
10	11.9	59.0	11.4	7.0
10	16.3	71.9	8.3	11.7
11	15.7	69.4	9.3	10.9
11	19.2	65.7	5.3	12.6
12	16.2	65.0	10.0	10.5
13	19.3	73.5	12.3	14.2
13	5.5	66.7	9.0	3.7
14	8.7	71.0	5.5	6.2
15	24.5	49.6	15.6	12.2
15	20.7	76.2	5.2	15.8
15	20.6	64.2	6.4	13.2
16	22.6	71.1	10.0	16.1
17	9.1	67.6	6.6	6.2
17	24.3	49.8	15.3	12.1
17	9.1	67.6	6.6	6.2
18	23.0	66.3	13.1	15.2
18	7.6	73.8	5.1	5.6
18	23.2	63.2	13.8	14.7
18	13.0	55.0	10.9	7.2
18	15.7	67.4	14.7	10.6
20	9.1	62.6	7.8	5.7
21	18.7	57.8	12.8	10.8
21	9.3	46.8	13.3	4.4
23	17.0	53.0	15.7	9.0
25	13.5	54.7	12.4	7.4
28	21.1	54.0	18.1	11.4
28	22.9	70.0	10.9	16.0
28	22.8	67.0	11.6	15.3
28	20.3	67.4	12.6	13.7
34	18.0	71.0	12.1	12.8
48	16.5	77.2	4.7	12.7

变量	曲线下面积	标准误^*	渐进 Sig.^#	渐近95%可信区间
变量	曲线下面积	标准误^*	渐进 Sig.^#	下限	上限
白细胞计数	0.790	0.040	0.000	0.712	0.867
淋巴细胞百分比	0.785	0.026	0.000	0.733	0.836
单核细胞百分比	0.702	0.050	0.000	0.603	0.800
淋巴细胞绝对值	0.887	0.023	0.000	0.842	0.832

变量	曲线下面积	标准误^*	渐进 Sig.^#	渐近95%可信区间
变量	曲线下面积	标准误^*	渐进 Sig.^#	下限	上限
白细胞计数	0.790	0.040	0.000	0.712	0.867
淋巴细胞百分比	0.785	0.026	0.000	0.733	0.836
单核细胞百分比	0.702	0.050	0.000	0.603	0.800
淋巴细胞绝对值	0.887	0.023	0.000	0.842	0.832

变量	曲线下面积	标准误^*	渐进 Sig.^#	渐近95%可信区间
变量	曲线下面积	标准误^*	渐进 Sig.^#	下限	上限
白细胞计数	0.821	0.029	0.000	0.764	0.878
淋巴细胞百分比	0.802	0.022	0.000	0.759	0.846
单核细胞百分比	0.679	0.045	0.000	0.590	0.767
淋巴细胞绝对值	0.920	0.016	0.000	0.888	0.952

RichHTML

PDF (PC)

[1]	吴梓文. 传染性单核细胞增多症患儿淋巴细胞散点图的改变[J]. 检验医学,2012,27(3):210-212.
[2]	雷宏涛,王杰民,王晓娟,等. EBV-IgM与EBV-DNA检测在小儿传染性单核细胞增多症诊治中的应用价值[J]. 陕西医学杂志,2014,43(4):427-428.
[3]	陈德林,潘丽. 48例传染性单核细胞增多症患儿EB病毒核酸定量和异型淋巴细胞的实验室临床意义[J]. 中国实用医药,2013,8(18):144-145.
[4]	杨菊红,胡丽华,李一荣,等. 血常规结果在常见传染病鉴别诊断中的应用[J]. 检验医学,2006,21(4):386-388.
[5]	陈海儿,张慧萍,黄伟萍. 儿童血象异型淋巴细胞患者的实验室指标相关性分析[J]. 中国卫生检验杂志,2013,23(12):2625-2626.
[6]	刘浩,蒋龙凤. EB病毒相关传染性单核细胞增多症102例临床分析[J]. 中华临床医师杂志:电子版,2013,7(18):8209-8212.